andrew huberman glp 1 Neuroscientist believes GLP-1s could eradicate obesity and fundamentally reshape public health. >> πLinkπ Dr Andrew Huberman notes a
Description
What that looks like at two years, what dose-reduction options exist, and what
Experts cant agree on whether that counts as doping.
UK clinical guidance included.
GLP-1 medications such as Ozempic and Wegovy have significantly reshaped the weight loss market by improving blood sugar regulation, insulin sensitivity, and appetite control
Evidence suggests GLP-1 therapies may modestly lower blood pressure while improving cardiometabolic risk in patients with diabetes and hypertension.
